The U.S. FDA has granted fast track status to pelareorep combination therapy for some KRAS-mutant, microsatellite-stable metastatic colorectal cancers.
BostonGene, a leader in AI-powered solutions for drug discovery and development, is transforming how pharmaceutical companies develop, target, and deliver cancer therapies — making precision medicine ...
Adoption and Implementation of Affordable Cancer Technologies in El Salvador: Identifying Implementation Strategies for Successful Cervical Cancer Prevention in Resource-Limited Settings The research ...
Cancer biology is a rapidly evolving field, with pathology and biomarker research at the forefront of innovations in ...
WEST LAFAYETTE, Ind. — Could a natural check on cancer be used to stop the disease? It’s possible, but to leverage a system that nature designed, we must first understand it. Researchers led by a team ...
People with the hereditary disease familial adenomatous polyposis (FAP) have a greatly increased risk of developing a malignant tumor of the duodenum. Researchers have now discovered a mechanism in ...
It’s not often that researchers get to share encouraging news when it comes to cancer. That’s why the recent announcement ...
New American Cancer Society Guidelines could make it easier for women living in rural areas to get cervical cancer screenings ...
Advances in cancer research have led to an increasing number and variety of cancer therapies in the development pipeline, but there are concerns that traditional processes for drug development, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results